Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular atrophy. Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Local authorities and relevant stakeholders are closely monitoring the situation as fresh developments unfold on the ground.